levodopa has been researched along with Acquired Metabolic Diseases, Brain in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Espay, AJ; Espay, KJ; Fasano, A; Krikorian, R; Ricciardi, L | 1 |
| Artigas, CF; Espino Ibáñez, A; Masmiquel Comas, L; Nicolau Ramis, J; Rivera Irigoín, R | 1 |
| Eidelberg, D; Feigin, A; Niethammer, M | 1 |
| Assmann, B; Bräutigam, C; de Klerk, JB; Dionisi-Vici, C; Häussler, M; Hoffmann, GF; Naumann, M; Steenbergen-Spanjers, GC; Strassburg, HM; Wevers, RA | 1 |
| Fahn, S; Furukawa, Y; Kish, SJ | 1 |
| Mercimek-Mahmutoglu, S; Stockler-Ipsiroglu, S | 1 |
| Blandini, F; Martignoni, E; Nappi, G; Pacchetti, C; Tassorelli, C; Zangaglia, R | 1 |
| Hanajima, R; Nomura, Y; Segawa, M; Ugawa, Y | 1 |
| Clement, F; Coubes, P; Defebvre, L; Destee, A; Devos, D; Moreau, C | 1 |
| Kanazawa, M; Kitani, Y; Kohno, Y; Ogawa, A; Shintaku, H; Takayanagi, M | 1 |
| Beard, JL; Bianco, LE; Earley, CJ; Jones, BC; Wiesinger, J | 1 |
| Marsden, CD; Obeso, JA; Rothwell, JC | 1 |
3 review(s) available for levodopa and Acquired Metabolic Diseases, Brain
| Article | Year |
|---|---|
Functional neuroimaging in Parkinson's disease.
Topics: Antiparkinson Agents; Brain Diseases, Metabolic; Cognition Disorders; Disease Progression; Dopamine; Dyskinesia, Drug-Induced; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Levodopa; Lewy Bodies; Magnetic Resonance Imaging; Neurotransmitter Agents; Parkinson Disease; Positron-Emission Tomography; Psychomotor Disorders; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon | 2012 |
Homocysteine and Parkinson's disease: a dangerous liaison?
Topics: Brain; Brain Diseases, Metabolic; Causality; Homocysteine; Humans; Hyperhomocysteinemia; Levodopa; Nerve Degeneration; Parkinson Disease | 2007 |
Somatosensory evoked potentials in myoclonus.
Topics: Brain Diseases, Metabolic; Cerebral Cortex; Clonazepam; Electroencephalography; Electromyography; Evoked Potentials, Somatosensory; Humans; Levodopa; Myoclonus; Parkinson Disease; Pyramidal Tracts | 1986 |
9 other study(ies) available for levodopa and Acquired Metabolic Diseases, Brain
| Article | Year |
|---|---|
Dopamine dysregulation syndrome with psychosis in 24-hour intestinal levodopa infusion for Parkinson's disease.
Topics: Antiparkinson Agents; Antipsychotic Agents; Brain Diseases, Metabolic; Capgras Syndrome; Clozapine; Dopamine; Hallucinations; Humans; Infusions, Parenteral; Levodopa; Male; Middle Aged; Psychoses, Substance-Induced | 2016 |
[Extrapyramidal symptoms due to calcinosis cerebri in a patient with unknown primary hypoparathyroidism].
Topics: Basal Ganglia Diseases; Brain Diseases, Metabolic; Calcinosis; Calcitriol; Calcium; Cognition Disorders; Depressive Disorder; Diagnosis, Differential; Dyslipidemias; Female; Gait Disorders, Neurologic; Gluconates; Humans; Hypoparathyroidism; Levodopa; Magnesium; Middle Aged; Syndrome | 2012 |
Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia.
Topics: Amino Acid Metabolism, Inborn Errors; Biogenic Monoamines; Brain Diseases, Metabolic; Child; Child, Preschool; Chromatography, High Pressure Liquid; Dopamine Agents; Dystonia; Female; Humans; Infant; Levodopa; Male; Mutation; Neurotransmitter Agents; Polymorphism, Genetic; Terminology as Topic; Tyrosine 3-Monooxygenase | 2003 |
Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency.
Topics: Amino Acid Metabolism, Inborn Errors; Brain Diseases, Metabolic; Dystonia; GTP Cyclohydrolase; Humans; Levodopa; Male; Mutation; Phenotype; Tyrosine 3-Monooxygenase | 2004 |
Cerebral folate deficiency and folinic acid treatment in hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) syndrome.
Topics: Antiparkinson Agents; Atrophy; Basal Ganglia; Brain Diseases, Metabolic; Carbidopa; Cerebellum; Demyelinating Diseases; Dystonia; Female; Folic Acid Deficiency; Humans; Leucovorin; Levodopa; Male; Syndrome; Tetrahydrofolates; Treatment Outcome; Vitamin B Complex | 2007 |
Intracortical inhibition of the motor cortex in Segawa disease (DYT5).
Topics: Adult; Basal Ganglia; Biopterins; Brain Diseases, Metabolic; Diagnosis, Differential; Dopamine; Dopamine Agents; Dystonic Disorders; Evoked Potentials, Motor; Female; gamma-Aminobutyric Acid; GTP Cyclohydrolase; Humans; Interneurons; Levodopa; Male; Middle Aged; Motor Cortex; Muscle, Skeletal; Neural Inhibition; Neural Pathways; Phenotype; Transcranial Magnetic Stimulation | 2007 |
Neurodegeneration with brain iron accumulation: clinical, radiographic and genetic heterogeneity and corresponding therapeutic options.
Topics: Adolescent; Brain; Brain Diseases, Metabolic; Diagnosis, Differential; DNA Mutational Analysis; Dystonia; Female; Genetic Predisposition to Disease; Humans; Iron; Iron Metabolism Disorders; Levodopa; Magnetic Resonance Imaging; Male; Middle Aged; Mutation; Neurodegenerative Diseases; Pantothenate Kinase-Associated Neurodegeneration; Phosphotransferases (Alcohol Group Acceptor); Treatment Outcome | 2007 |
A case of 6-pyruvoyl-tetrahydropterin synthase deficiency demonstrates a more significant correlation of L-Dopa dosage with serum prolactin levels than CSF homovanillic acid levels.
Topics: 5-Hydroxytryptophan; Biomarkers; Biopterins; Brain Diseases, Metabolic; Child, Preschool; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Homovanillic Acid; Humans; Hypothalamo-Hypophyseal System; Levodopa; Phosphorus-Oxygen Lyases; Predictive Value of Tests; Prolactin | 2008 |
Iron deficiency alters dopamine uptake and response to L-DOPA injection in Sprague-Dawley rats.
Topics: Animals; Brain; Brain Diseases, Metabolic; Caudate Nucleus; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Extracellular Fluid; Iron Deficiencies; Levodopa; Male; Microdialysis; Neural Pathways; Norepinephrine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Restless Legs Syndrome; RNA, Messenger; Substantia Nigra; Up-Regulation | 2008 |